Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Can-Fite BioPharma completes patient enrollment in CF101 Phase II/III psoriasis trial

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that all patients enrolled in its Phase II/III psoriasis trial for the Company's drug candidate CF101 have completed the study's 32 week treatment protocol.

4 Feb 2015

AMS sponsors ‘Healthy Body Healthy Mind’ series to promote awareness on stress urinary incontinence

American Medical Systems Inc. (AMS), a subsidiary of Endo International plc and leading provider of medical technologies for pelvic health, is proud to be a sponsor of an episode of the popular Healthy Body Healthy Mind series titled "Managing Female Stress Urinary Incontinence."

4 Feb 2015

Study demonstrates that pelvic floor muscle training improves erectile function

Preliminary results of a four-month clinical trial offer hope for the thousands of baby boomer men turning 50 every minute, with nearly 6-in-10 of them experiencing erectile dysfunction. Proving pelvic floor exercise can help turn back the clock on sexual decline, the study demonstrates that weighted resistance training improves erectile function in both healthy men and those with erectile dysfunction.

12 Jan 2015

Palatin begins bremelanotide phase 3 study for treatment of female sexual dysfunction

Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential, today announced that it has started its bremelanotide pivotal registration program.

29 Dec 2014

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported that it will initiate a pre-clinical development program of its next generation drug CF602 for the indication of sexual dysfunction. Upon successful completion, the company intends to file an IND with the FDA to allow human Phase I studies.

9 Dec 2014

Auxilium Pharmaceuticals presents STENDRA clinical data for ED treatment at SMSNA Scientific Meeting

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that data were presented regarding the use of STENDRA® (avanafil) tablets for the treatment of erectile dysfunction (ED) at the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (SMSNA) held in Miami from November 20-23, 2014.

20 Nov 2014

Men with BPH need to discuss 'male orgasmic dysfunction' with doctors prior to any treatment

NeoTract, Inc., today welcomes the publication of a paper in the British Journal of Urology International which calls for men suffering from enlarged prostate to discuss with their doctors the likely impact of treatment options on their sexual function. Most procedures and many medications can cause sexual dysfunction. Clinical studies show that treatment with the UroLift system has not been associated with any new onset of sustained ejaculatory or erectile dysfunction.

31 Oct 2014

New drug naming system to be presented at ECNP conference in Berlin

What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment.

20 Oct 2014

Endocrine Society issues updated Clinical Practice Guideline on androgens in women

The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women.

5 Oct 2014

Endo resolves claims relating to vaginal mesh products

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that it has reached master settlement agreements with several of the remaining leading plaintiffs' law firms to resolve claims relating to vaginal mesh products sold by Endo's AMS subsidiary.

1 Oct 2014

UC Davis research highlights need for better guidance for primary care providers

Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published in the September-October issue of the Journal of the American Board of Family Medicine.

30 Sep 2014

ED more prevalent than previously thought

Specialists in treatment of erectile dysfunction recognize that ED is more prevalent than previously recognized.

29 Sep 2014

American men have worse access to reproductive and sexual health care, shows research

Compared with women, American men have worse access to reproductive and sexual health care, research shows, a disparity fueled in part by the lack of standard clinical guidelines on the types and timing of exams, tests and treatments that should be offered to all men of reproductive age.

10 Sep 2014

Men who are not well educated about prostate cancer face decisional conflict, finds UCLA study

They say knowledge is power, and a new UCLA study has shown this is definitely the case when it comes to men making the best decisions about how to treat their prostate cancer.

28 Aug 2014

Loyola's Sexual Wellness Clinic to help break down the stigma associated with sexual dysfunction

Sexual dysfunction among couples is common, yet it often goes untreated, according to specialists at Loyola University Health System's Sexual Wellness Clinic.

31 Jul 2014

Researchers identify two classes of anti-depressants that reduce symptoms of depression

Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. When depression co-exists with cancer, patients may be at an increased risk of death from cancer and from suicide.

28 Jun 2014

Researchers perform systematic review to identify best treatments for cancer-related depression

27 Jun 2014

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

29 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

Study on premature ejaculation could lead to improved diagnosis and treatment for affected men

There are many misconceptions and unknowns about premature ejaculation in the medical community and the general population. Two papers, both being published simultaneously in Sexual Medicine and the Journal of Sexual Medicine, provide much-needed answers that could lead to improved diagnosis and treatment for affected men.

22 May 2014

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Can-Fite BioPharma completes patient enrollment in CF101 Phase II/III psoriasis trial

AMS sponsors ‘Healthy Body Healthy Mind’ series to promote awareness on stress urinary incontinence

Study demonstrates that pelvic floor muscle training improves erectile function

Palatin begins bremelanotide phase 3 study for treatment of female sexual dysfunction

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Auxilium Pharmaceuticals presents STENDRA clinical data for ED treatment at SMSNA Scientific Meeting

Men with BPH need to discuss 'male orgasmic dysfunction' with doctors prior to any treatment

New drug naming system to be presented at ECNP conference in Berlin

Endocrine Society issues updated Clinical Practice Guideline on androgens in women

Endo resolves claims relating to vaginal mesh products

UC Davis research highlights need for better guidance for primary care providers

ED more prevalent than previously thought

American men have worse access to reproductive and sexual health care, shows research

Men who are not well educated about prostate cancer face decisional conflict, finds UCLA study

Loyola's Sexual Wellness Clinic to help break down the stigma associated with sexual dysfunction

Researchers identify two classes of anti-depressants that reduce symptoms of depression

Researchers perform systematic review to identify best treatments for cancer-related depression

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Study on premature ejaculation could lead to improved diagnosis and treatment for affected men

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in